EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis/chronic fatigue syndrome or control serum

Audrey A Ryback iD, Charles B Hillier, Camila M Loureiro iD, Chris P Ponting iD, Caroline F Dalton

PLOS One · 2026

DOI: 10.1371/journal.pone.0341334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Audrey A Ryback und 4 weiteren Autor:innen. Beteiligte Einrichtung: MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. Hauptthemen laut MEDLINE: Fatigue Syndrome, Chronic, Myoblasts, Mitochondria, Serum. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Action for M.E..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myalgic Encephalomyelitis (ME) / Chronic Fatigue Syndrome is a disease of uncertain aetiology that affects up to 400,000 individuals in the UK. Exposure of cultured cells to the sera of people with ME has been proposed to cause phenotypic changes in these cells in vitro when compared to sera from healthy controls. ME serum factors causing these changes could inform the development of diagnostic tests. In this study, we performed a large-scale, pre-registered replication of an experiment from Fluge et al (2016) that reported an increase in maximal respiratory capacity in healthy myoblasts after treatment with serum from people with ME compared to serum from healthy controls. We replicated the original experiment with a larger sample size, using sera from 67 people with ME and 53 controls to treat healthy cultured myoblasts, and generated results from over 1,700 mitochondrial stress tests performed with a Seahorse Bioanalyser. We observed no significant differences between treatment with ME or healthy control sera for our primary outcome of interest, oxygen consumption rate at maximal respiratory capacity. Results from our study provide strong evidence against the hypothesis that ME blood factors differentially affect healthy myoblast mitochondrial phenotypes in vitro .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatigue Syndrome, ChronicMyoblastsMitochondriaSerumHumansPhenotypeOxygen ConsumptionFemaleMaleAdult

Autor:innen und Institutionen

  • MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.
  • c/o Action for ME, Bristol, United Kingdom.
  • Department of Neurosciences and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Biomolecular Sciences Research Centre, Sheffield Hallam University, City Campus, Sheffield, United Kingdom.
  • Advanced Wellbeing Research Centre, Sheffield Hallam University, Olympic Legacy Park, Sheffield, United Kingdom.

ORCID-Profile: Audrey A Ryback, Camila M Loureiro, Chris P Ponting

Förderung

  • Action for M.E.

Zitieren

APA

Ryback, A. A., Hillier, C. B., Loureiro, C. M., Ponting, C. P., & Dalton, C. F. (2026). Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis/chronic fatigue syndrome or control serum. PLOS One. https://doi.org/10.1371/journal.pone.0341334

Vancouver

Ryback AA, Hillier CB, Loureiro CM, Ponting CP, Dalton CF. Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis/chronic fatigue syndrome or control serum. PLOS One. 2026. doi:10.1371/journal.pone.0341334

BibTeX
@article{Ryback2026,
  author = {Ryback, Audrey A and Hillier, Charles B and Loureiro, Camila M and Ponting, Chris P and Dalton, Caroline F},
  title = {Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis/chronic fatigue syndrome or control serum},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0341334}
}
Kostenlos starten →